Estonia - Cardiac Glycosides Use
Since 2014, Estonia Cardiac Glycosides Use was down by 11.1% year on year. In 2019, the country was number 4 comparing other countries in Cardiac Glycosides Use at 2.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Estonia is overtaken by Lithuania, which was number 3 at 2.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Germany with 2.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia lead the ranking with 3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a fall of 3.2% versus 2018. Netherlands recorded the best 5 years average growth at -4.4% per year, while Chile recorded the worst performance at -18.6% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 2.50 |
| 2018 | 3.10 |
| 2017 | 3.30 |
| 2016 | 3.70 |
| 2015 | 4.20 |
How does Estonia rank in Cardiac Glycosides Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
3 | 2019 | -6.3 % | -5.1 % | View data |
| 1 |
#1
Latvia
|
3 | 2019 | -3.2 % | -5.1 % | View data |
| 3 |
#3
Lithuania
|
3 | 2019 | -3.6 % | -6.6 % | View data |
| 4 |
#4
Estonia
|
3 | 2019 | -19.4 % | -11.1 % | View data |
| 5 |
#5
Germany
|
2 | 2019 | -20.0 % | -11.4 % | View data |